Global Retinal Drugs and Biologics Market Growth 2018-2023

Publisher Name :
Date: 22-Oct-2018
No. of pages: 163

Retina is a very sensitive and delicate part of human eye which is responsible for receiving and processing light to convert into neural signals and send to the brain for visual activity. The disorders related to retinal health include age-related macular degeneration, diabetic retinopathy, infectious retinitis, macular edema, macular hole, retinoblastoma, retinal degeneration, retinoschisis and uveitis etc. There are various types of retinal disorders but most of them cause visual symptoms.

Over the next five years, LPI(LP Information) projects that Retinal Drugs and Biologics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Retinal Drugs and Biologics market for 2018-2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Retinal Drugs and Biologics market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

- Age Related Macular Degeneration

- Diabetic Retinopathy

- Ocular Inflammatory Disease (Uveitis)

- Macular Hole

Segmentation by application:

- Hospitals

- Clinics

- Others

This report also splits the market by region:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

- ALLERGAN

- AbbVie

- Alimera Sciences

- Janssen Biotech

- Swedish Orphan Biovitrum

- Roche

- Bristol-Myers Squibb

- Genzyme

- Genentech

- OCULAR THERAPEUTIX

- Bausch & Lomb

- UCBCares

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Retinal Drugs and Biologics consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

- To understand the structure of Retinal Drugs and Biologics market by identifying its various subsegments.

- Focuses on the key global Retinal Drugs and Biologics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Retinal Drugs and Biologics with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Retinal Drugs and Biologics submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Retinal Drugs and Biologics Market Growth 2018-2023

Table of Contents

2018-2023 Global Retinal Drugs and Biologics Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Retinal Drugs and Biologics Consumption 2013-2023
2.1.2 Retinal Drugs and Biologics Consumption CAGR by Region
2.2 Retinal Drugs and Biologics Segment by Type
2.2.1 Age Related Macular Degeneration
2.2.2 Diabetic Retinopathy
2.2.3 Ocular Inflammatory Disease (Uveitis)
2.2.4 Macular Hole
2.3 Retinal Drugs and Biologics Consumption by Type
2.3.1 Global Retinal Drugs and Biologics Consumption Market Share by Type (2013-2018)
2.3.2 Global Retinal Drugs and Biologics Revenue and Market Share by Type (2013-2018)
2.3.3 Global Retinal Drugs and Biologics Sale Price by Type (2013-2018)
2.4 Retinal Drugs and Biologics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Retinal Drugs and Biologics Consumption by Application
2.5.1 Global Retinal Drugs and Biologics Consumption Market Share by Application (2013-2018)
2.5.2 Global Retinal Drugs and Biologics Value and Market Share by Application (2013-2018)
2.5.3 Global Retinal Drugs and Biologics Sale Price by Application (2013-2018)

3 Global Retinal Drugs and Biologics by Players
3.1 Global Retinal Drugs and Biologics Sales Market Share by Players
3.1.1 Global Retinal Drugs and Biologics Sales by Players (2016-2018)
3.1.2 Global Retinal Drugs and Biologics Sales Market Share by Players (2016-2018)
3.2 Global Retinal Drugs and Biologics Revenue Market Share by Players
3.2.1 Global Retinal Drugs and Biologics Revenue by Players (2016-2018)
3.2.2 Global Retinal Drugs and Biologics Revenue Market Share by Players (2016-2018)
3.3 Global Retinal Drugs and Biologics Sale Price by Players
3.4 Global Retinal Drugs and Biologics Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Retinal Drugs and Biologics Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Retinal Drugs and Biologics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Retinal Drugs and Biologics by Regions
4.1 Retinal Drugs and Biologics by Regions
4.1.1 Global Retinal Drugs and Biologics Consumption by Regions
4.1.2 Global Retinal Drugs and Biologics Value by Regions
4.2 Americas Retinal Drugs and Biologics Consumption Growth
4.3 APAC Retinal Drugs and Biologics Consumption Growth
4.4 Europe Retinal Drugs and Biologics Consumption Growth
4.5 Middle East & Africa Retinal Drugs and Biologics Consumption Growth

5 Americas
5.1 Americas Retinal Drugs and Biologics Consumption by Countries
5.1.1 Americas Retinal Drugs and Biologics Consumption by Countries (2013-2018)
5.1.2 Americas Retinal Drugs and Biologics Value by Countries (2013-2018)
5.2 Americas Retinal Drugs and Biologics Consumption by Type
5.3 Americas Retinal Drugs and Biologics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Retinal Drugs and Biologics Consumption by Countries
6.1.1 APAC Retinal Drugs and Biologics Consumption by Countries (2013-2018)
6.1.2 APAC Retinal Drugs and Biologics Value by Countries (2013-2018)
6.2 APAC Retinal Drugs and Biologics Consumption by Type
6.3 APAC Retinal Drugs and Biologics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Retinal Drugs and Biologics by Countries
7.1.1 Europe Retinal Drugs and Biologics Consumption by Countries (2013-2018)
7.1.2 Europe Retinal Drugs and Biologics Value by Countries (2013-2018)
7.2 Europe Retinal Drugs and Biologics Consumption by Type
7.3 Europe Retinal Drugs and Biologics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Retinal Drugs and Biologics by Countries
8.1.1 Middle East & Africa Retinal Drugs and Biologics Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Retinal Drugs and Biologics Value by Countries (2013-2018)
8.2 Middle East & Africa Retinal Drugs and Biologics Consumption by Type
8.3 Middle East & Africa Retinal Drugs and Biologics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Retinal Drugs and Biologics Distributors
10.3 Retinal Drugs and Biologics Customer

11 Global Retinal Drugs and Biologics Market Forecast
11.1 Global Retinal Drugs and Biologics Consumption Forecast (2018-2023)
11.2 Global Retinal Drugs and Biologics Forecast by Regions
11.2.1 Global Retinal Drugs and Biologics Forecast by Regions (2018-2023)
11.2.2 Global Retinal Drugs and Biologics Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Retinal Drugs and Biologics Forecast by Type
11.8 Global Retinal Drugs and Biologics Forecast by Application

12 Key Players Analysis
12.1 ALLERGAN
12.1.1 Company Details
12.1.2 Retinal Drugs and Biologics Product Offered
12.1.3 ALLERGAN Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 ALLERGAN News
12.2 AbbVie
12.2.1 Company Details
12.2.2 Retinal Drugs and Biologics Product Offered
12.2.3 AbbVie Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 AbbVie News
12.3 Alimera Sciences
12.3.1 Company Details
12.3.2 Retinal Drugs and Biologics Product Offered
12.3.3 Alimera Sciences Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Alimera Sciences News
12.4 Janssen Biotech
12.4.1 Company Details
12.4.2 Retinal Drugs and Biologics Product Offered
12.4.3 Janssen Biotech Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Janssen Biotech News
12.5 Swedish Orphan Biovitrum
12.5.1 Company Details
12.5.2 Retinal Drugs and Biologics Product Offered
12.5.3 Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Swedish Orphan Biovitrum News
12.6 Roche
12.6.1 Company Details
12.6.2 Retinal Drugs and Biologics Product Offered
12.6.3 Roche Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Roche News
12.7 Bristol-Myers Squibb
12.7.1 Company Details
12.7.2 Retinal Drugs and Biologics Product Offered
12.7.3 Bristol-Myers Squibb Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Bristol-Myers Squibb News
12.8 Genzyme
12.8.1 Company Details
12.8.2 Retinal Drugs and Biologics Product Offered
12.8.3 Genzyme Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Genzyme News
12.9 Genentech
12.9.1 Company Details
12.9.2 Retinal Drugs and Biologics Product Offered
12.9.3 Genentech Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Genentech News
12.10 OCULAR THERAPEUTIX
12.10.1 Company Details
12.10.2 Retinal Drugs and Biologics Product Offered
12.10.3 OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 OCULAR THERAPEUTIX News
12.11 Bausch & Lomb
12.12 UCBCares

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Retinal Drugs and Biologics
Table Product Specifications of Retinal Drugs and Biologics
Figure Retinal Drugs and Biologics Report Years Considered
Figure Market Research Methodology
Figure Global Retinal Drugs and Biologics Consumption Growth Rate 2013-2023 (K Units)
Figure Global Retinal Drugs and Biologics Value Growth Rate 2013-2023 ($ Millions)
Table Retinal Drugs and Biologics Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Age Related Macular Degeneration
Table Major Players of Age Related Macular Degeneration
Figure Product Picture of Diabetic Retinopathy
Table Major Players of Diabetic Retinopathy
Figure Product Picture of Ocular Inflammatory Disease (Uveitis)
Table Major Players of Ocular Inflammatory Disease (Uveitis)
Figure Product Picture of Macular Hole
Table Major Players of Macular Hole
Table Global Consumption Sales by Type (2013-2018)
Table Global Retinal Drugs and Biologics Consumption Market Share by Type (2013-2018)
Figure Global Retinal Drugs and Biologics Consumption Market Share by Type (2013-2018)
Table Global Retinal Drugs and Biologics Revenue by Type (2013-2018) ($ million)
Table Global Retinal Drugs and Biologics Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Retinal Drugs and Biologics Value Market Share by Type (2013-2018)
Table Global Retinal Drugs and Biologics Sale Price by Type (2013-2018)
Figure Retinal Drugs and Biologics Consumed in Hospitals
Figure Global Retinal Drugs and Biologics Market: Hospitals (2013-2018) (K Units)
Figure Global Retinal Drugs and Biologics Market: Hospitals (2013-2018) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Retinal Drugs and Biologics Consumed in Clinics
Figure Global Retinal Drugs and Biologics Market: Clinics (2013-2018) (K Units)
Figure Global Retinal Drugs and Biologics Market: Clinics (2013-2018) ($ Millions)
Figure Global Clinics YoY Growth ($ Millions)
Figure Retinal Drugs and Biologics Consumed in Others
Figure Global Retinal Drugs and Biologics Market: Others (2013-2018) (K Units)
Figure Global Retinal Drugs and Biologics Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Retinal Drugs and Biologics Consumption Market Share by Application (2013-2018)
Figure Global Retinal Drugs and Biologics Consumption Market Share by Application (2013-2018)
Table Global Retinal Drugs and Biologics Value by Application (2013-2018)
Table Global Retinal Drugs and Biologics Value Market Share by Application (2013-2018)
Figure Global Retinal Drugs and Biologics Value Market Share by Application (2013-2018)
Table Global Retinal Drugs and Biologics Sale Price by Application (2013-2018)
Table Global Retinal Drugs and Biologics Sales by Players (2016-2018) (K Units)
Table Global Retinal Drugs and Biologics Sales Market Share by Players (2016-2018)
Figure Global Retinal Drugs and Biologics Sales Market Share by Players in 2016
Figure Global Retinal Drugs and Biologics Sales Market Share by Players in 2017
Table Global Retinal Drugs and Biologics Revenue by Players (2016-2018) ($ Millions)
Table Global Retinal Drugs and Biologics Revenue Market Share by Players (2016-2018)
Figure Global Retinal Drugs and Biologics Revenue Market Share by Players in 2016
Figure Global Retinal Drugs and Biologics Revenue Market Share by Players in 2017
Table Global Retinal Drugs and Biologics Sale Price by Players (2016-2018)
Figure Global Retinal Drugs and Biologics Sale Price by Players in 2017
Table Global Retinal Drugs and Biologics Manufacturing Base Distribution and Sales Area by Players
Table Players Retinal Drugs and Biologics Products Offered
Table Retinal Drugs and Biologics Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Retinal Drugs and Biologics Consumption by Regions 2013-2018 (K Units)
Table Global Retinal Drugs and Biologics Consumption Market Share by Regions 2013-2018
Figure Global Retinal Drugs and Biologics Consumption Market Share by Regions 2013-2018
Table Global Retinal Drugs and Biologics Value by Regions 2013-2018 ($ Millions)
Table Global Retinal Drugs and Biologics Value Market Share by Regions 2013-2018
Figure Global Retinal Drugs and Biologics Value Market Share by Regions 2013-2018
Figure Americas Retinal Drugs and Biologics Consumption 2013-2018 (K Units)
Figure Americas Retinal Drugs and Biologics Value 2013-2018 ($ Millions)
Figure APAC Retinal Drugs and Biologics Consumption 2013-2018 (K Units)
Figure APAC Retinal Drugs and Biologics Value 2013-2018 ($ Millions)
Figure Europe Retinal Drugs and Biologics Consumption 2013-2018 (K Units)
Figure Europe Retinal Drugs and Biologics Value 2013-2018 ($ Millions)
Figure Middle East & Africa Retinal Drugs and Biologics Consumption 2013-2018 (K Units)
Figure Middle East & Africa Retinal Drugs and Biologics Value 2013-2018 ($ Millions)
Table Americas Retinal Drugs and Biologics Consumption by Countries (2013-2018) (K Units)
Table Americas Retinal Drugs and Biologics Consumption Market Share by Countries (2013-2018)
Figure Americas Retinal Drugs and Biologics Consumption Market Share by Countries in 2017
Table Americas Retinal Drugs and Biologics Value by Countries (2013-2018) ($ Millions)
Table Americas Retinal Drugs and Biologics Value Market Share by Countries (2013-2018)
Figure Americas Retinal Drugs and Biologics Value Market Share by Countries in 2017
Table Americas Retinal Drugs and Biologics Consumption by Type (2013-2018) (K Units)
Table Americas Retinal Drugs and Biologics Consumption Market Share by Type (2013-2018)
Figure Americas Retinal Drugs and Biologics Consumption Market Share by Type in 2017
Table Americas Retinal Drugs and Biologics Consumption by Application (2013-2018) (K Units)
Table Americas Retinal Drugs and Biologics Consumption Market Share by Application (2013-2018)
Figure Americas Retinal Drugs and Biologics Consumption Market Share by Application in 2017
Figure United States Retinal Drugs and Biologics Consumption Growth 2013-2018 (K Units)
Figure United States Retinal Drugs and Biologics Value Growth 2013-2018 ($ Millions)
Figure Canada Retinal Drugs and Biologics Consumption Growth 2013-2018 (K Units)
Figure Canada Retinal Drugs and Biologics Value Growth 2013-2018 ($ Millions)
Figure Mexico Retinal Drugs and Biologics Consumption Growth 2013-2018 (K Units)
Figure Mexico Retinal Drugs and Biologics Value Growth 2013-2018 ($ Millions)
Table APAC Retinal Drugs and Biologics Consumption by Countries (2013-2018) (K Units)
Table APAC Retinal Drugs and Biologics Consumption Market Share by Countries (2013-2018)
Figure APAC Retinal Drugs and Biologics Consumption Market Share by Countries in 2017
Table APAC Retinal Drugs and Biologics Value by Countries (2013-2018) ($ Millions)
Table APAC Retinal Drugs and Biologics Value Market Share by Countries (2013-2018)
Figure APAC Retinal Drugs and Biologics Value Market Share by Countries in 2017
Table APAC Retinal Drugs and Biologics Consumption by Type (2013-2018) (K Units)
Table APAC Retinal Drugs and Biologics Consumption Market Share by Type (2013-2018)
Figure APAC Retinal Drugs and Biologics Consumption Market Share by Type in 2017
Table APAC Retinal Drugs and Biologics Consumption by Application (2013-2018) (K Units)
Table APAC Retinal Drugs and Biologics Consumption Market Share by Application (2013-2018)
Figure APAC Retinal Drugs and Biologics Consumption Market Share by Application in 2017
Figure China Retinal Drugs and Biologics Consumption Growth 2013-2018 (K Units)
Figure China Retinal Drugs and Biologics Value Growth 2013-2018 ($ Millions)
Figure Japan Retinal Drugs and Biologics Consumption Growth 2013-2018 (K Units)
Figure Japan Retinal Drugs and Biologics Value Growth 2013-2018 ($ Millions)
Figure Korea Retinal Drugs and Biologics Consumption Growth 2013-2018 (K Units)
Figure Korea Retinal Drugs and Biologics Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Retinal Drugs and Biologics Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Retinal Drugs and Biologics Value Growth 2013-2018 ($ Millions)
Figure India Retinal Drugs and Biologics Consumption Growth 2013-2018 (K Units)
Figure India Retinal Drugs and Biologics Value Growth 2013-2018 ($ Millions)
Figure Australia Retinal Drugs and Biologics Consumption Growth 2013-2018 (K Units)
Figure Australia Retinal Drugs and Biologics Value Growth 2013-2018 ($ Millions)
Table Europe Retinal Drugs and Biologics Consumption by Countries (2013-2018) (K Units)
Table Europe Retinal Drugs and Biologics Consumption Market Share by Countries (2013-2018)
Figure Europe Retinal Drugs and Biologics Consumption Market Share by Countries in 2017
Table Europe Retinal Drugs and Biologics Value by Countries (2013-2018) ($ Millions)
Table Europe Retinal Drugs and Biologics Value Market Share by Countries (2013-2018)
Figure Europe Retinal Drugs and Biologics Value Market Share by Countries in 2017
Table Europe Retinal Drugs and Biologics Consumption by Type (2013-2018) (K Units)
Table Europe Retinal Drugs and Biologics Consumption Market Share by Type (2013-2018)
Figure Europe Retinal Drugs and Biologics Consumption Market Share by Type in 2017
Table Europe Retinal Drugs and Biologics Consumption by Application (2013-2018) (K Units)
Table Europe Retinal Drugs and Biologics Consumption Market Share by Application (2013-2018)
Figure Europe Retinal Drugs and Biologics Consumption Market Share by Application in 2017
Figure Germany Retinal Drugs and Biologics Consumption Growth 2013-2018 (K Units)
Figure Germany Retinal Drugs and Biologics Value Growth 2013-2018 ($ Millions)
Figure France Retinal Drugs and Biologics Consumption Growth 2013-2018 (K Units)
Figure France Retinal Drugs and Biologics Value Growth 2013-2018 ($ Millions)
Figure UK Retinal Drugs and Biologics Consumption Growth 2013-2018 (K Units)
Figure UK Retinal Drugs and Biologics Value Growth 2013-2018 ($ Millions)
Figure Italy Retinal Drugs and Biologics Consumption Growth 2013-2018 (K Units)
Figure Italy Retinal Drugs and Biologics Value Growth 2013-2018 ($ Millions)
Figure Russia Retinal Drugs and Biologics Consumption Growth 2013-2018 (K Units)
Figure Russia Retinal Drugs and Biologics Value Growth 2013-2018 ($ Millions)
Figure Spain Retinal Drugs and Biologics Consumption Growth 2013-2018 (K Units)
Figure Spain Retinal Drugs and Biologics Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Retinal Drugs and Biologics Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Retinal Drugs and Biologics Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Retinal Drugs and Biologics Consumption Market Share by Countries in 2017
Table Middle East & Africa Retinal Drugs and Biologics Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Retinal Drugs and Biologics Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Retinal Drugs and Biologics Value Market Share by Countries in 2017
Table Middle East & Africa Retinal Drugs and Biologics Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Retinal Drugs and Biologics Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Retinal Drugs and Biologics Consumption Market Share by Type in 2017
Table Middle East & Africa Retinal Drugs and Biologics Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Retinal Drugs and Biologics Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Retinal Drugs and Biologics Consumption Market Share by Application in 2017
Figure Egypt Retinal Drugs and Biologics Consumption Growth 2013-2018 (K Units)
Figure Egypt Retinal Drugs and Biologics Value Growth 2013-2018 ($ Millions)
Figure South Africa Retinal Drugs and Biologics Consumption Growth 2013-2018 (K Units)
Figure South Africa Retinal Drugs and Biologics Value Growth 2013-2018 ($ Millions)
Figure Israel Retinal Drugs and Biologics Consumption Growth 2013-2018 (K Units)
Figure Israel Retinal Drugs and Biologics Value Growth 2013-2018 ($ Millions)
Figure Turkey Retinal Drugs and Biologics Consumption Growth 2013-2018 (K Units)
Figure Turkey Retinal Drugs and Biologics Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Retinal Drugs and Biologics Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Retinal Drugs and Biologics Value Growth 2013-2018 ($ Millions)
Table Retinal Drugs and Biologics Distributors List
Table Retinal Drugs and Biologics Customer List
Figure Global Retinal Drugs and Biologics Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Retinal Drugs and Biologics Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Retinal Drugs and Biologics Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Retinal Drugs and Biologics Consumption Market Forecast by Regions
Table Global Retinal Drugs and Biologics Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Retinal Drugs and Biologics Value Market Share Forecast by Regions
Figure Americas Retinal Drugs and Biologics Consumption 2018-2023 (K Units)
Figure Americas Retinal Drugs and Biologics Value 2018-2023 ($ Millions)
Figure APAC Retinal Drugs and Biologics Consumption 2018-2023 (K Units)
Figure APAC Retinal Drugs and Biologics Value 2018-2023 ($ Millions)
Figure Europe Retinal Drugs and Biologics Consumption 2018-2023 (K Units)
Figure Europe Retinal Drugs and Biologics Value 2018-2023 ($ Millions)
Figure Middle East & Africa Retinal Drugs and Biologics Consumption 2018-2023 (K Units)
Figure Middle East & Africa Retinal Drugs and Biologics Value 2018-2023 ($ Millions)
Figure United States Retinal Drugs and Biologics Consumption 2018-2023 (K Units)
Figure United States Retinal Drugs and Biologics Value 2018-2023 ($ Millions)
Figure Canada Retinal Drugs and Biologics Consumption 2018-2023 (K Units)
Figure Canada Retinal Drugs and Biologics Value 2018-2023 ($ Millions)
Figure Mexico Retinal Drugs and Biologics Consumption 2018-2023 (K Units)
Figure Mexico Retinal Drugs and Biologics Value 2018-2023 ($ Millions)
Figure Brazil Retinal Drugs and Biologics Consumption 2018-2023 (K Units)
Figure Brazil Retinal Drugs and Biologics Value 2018-2023 ($ Millions)
Figure China Retinal Drugs and Biologics Consumption 2018-2023 (K Units)
Figure China Retinal Drugs and Biologics Value 2018-2023 ($ Millions)
Figure Japan Retinal Drugs and Biologics Consumption 2018-2023 (K Units)
Figure Japan Retinal Drugs and Biologics Value 2018-2023 ($ Millions)
Figure Korea Retinal Drugs and Biologics Consumption 2018-2023 (K Units)
Figure Korea Retinal Drugs and Biologics Value 2018-2023 ($ Millions)
Figure Southeast Asia Retinal Drugs and Biologics Consumption 2018-2023 (K Units)
Figure Southeast Asia Retinal Drugs and Biologics Value 2018-2023 ($ Millions)
Figure India Retinal Drugs and Biologics Consumption 2018-2023 (K Units)
Figure India Retinal Drugs and Biologics Value 2018-2023 ($ Millions)
Figure Australia Retinal Drugs and Biologics Consumption 2018-2023 (K Units)
Figure Australia Retinal Drugs and Biologics Value 2018-2023 ($ Millions)
Figure Germany Retinal Drugs and Biologics Consumption 2018-2023 (K Units)
Figure Germany Retinal Drugs and Biologics Value 2018-2023 ($ Millions)
Figure France Retinal Drugs and Biologics Consumption 2018-2023 (K Units)
Figure France Retinal Drugs and Biologics Value 2018-2023 ($ Millions)
Figure UK Retinal Drugs and Biologics Consumption 2018-2023 (K Units)
Figure UK Retinal Drugs and Biologics Value 2018-2023 ($ Millions)
Figure Italy Retinal Drugs and Biologics Consumption 2018-2023 (K Units)
Figure Italy Retinal Drugs and Biologics Value 2018-2023 ($ Millions)
Figure Russia Retinal Drugs and Biologics Consumption 2018-2023 (K Units)
Figure Russia Retinal Drugs and Biologics Value 2018-2023 ($ Millions)
Figure Spain Retinal Drugs and Biologics Consumption 2018-2023 (K Units)
Figure Spain Retinal Drugs and Biologics Value 2018-2023 ($ Millions)
Figure Egypt Retinal Drugs and Biologics Consumption 2018-2023 (K Units)
Figure Egypt Retinal Drugs and Biologics Value 2018-2023 ($ Millions)
Figure South Africa Retinal Drugs and Biologics Consumption 2018-2023 (K Units)
Figure South Africa Retinal Drugs and Biologics Value 2018-2023 ($ Millions)
Figure Israel Retinal Drugs and Biologics Consumption 2018-2023 (K Units)
Figure Israel Retinal Drugs and Biologics Value 2018-2023 ($ Millions)
Figure Turkey Retinal Drugs and Biologics Consumption 2018-2023 (K Units)
Figure Turkey Retinal Drugs and Biologics Value 2018-2023 ($ Millions)
Figure GCC Countries Retinal Drugs and Biologics Consumption 2018-2023 (K Units)
Figure GCC Countries Retinal Drugs and Biologics Value 2018-2023 ($ Millions)
Table Global Retinal Drugs and Biologics Consumption Forecast by Type (2018-2023) (K Units)
Table Global Retinal Drugs and Biologics Consumption Market Share Forecast by Type (2018-2023)
Table Global Retinal Drugs and Biologics Value Forecast by Type (2018-2023) ($ Millions)
Table Global Retinal Drugs and Biologics Value Market Share Forecast by Type (2018-2023)
Table Global Retinal Drugs and Biologics Consumption Forecast by Application (2018-2023) (K Units)
Table Global Retinal Drugs and Biologics Consumption Market Share Forecast by Application (2018-2023)
Table Global Retinal Drugs and Biologics Value Forecast by Application (2018-2023) ($ Millions)
Table Global Retinal Drugs and Biologics Value Market Share Forecast by Application (2018-2023)
Table ALLERGAN Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ALLERGAN Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure ALLERGAN Retinal Drugs and Biologics Market Share (2016-2018)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AbbVie Retinal Drugs and Biologics Market Share (2016-2018)
Table Alimera Sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alimera Sciences Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Alimera Sciences Retinal Drugs and Biologics Market Share (2016-2018)
Table Janssen Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Janssen Biotech Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Janssen Biotech Retinal Drugs and Biologics Market Share (2016-2018)
Table Swedish Orphan Biovitrum Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Swedish Orphan Biovitrum Retinal Drugs and Biologics Market Share (2016-2018)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Roche Retinal Drugs and Biologics Market Share (2016-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bristol-Myers Squibb Retinal Drugs and Biologics Market Share (2016-2018)
Table Genzyme Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Genzyme Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Genzyme Retinal Drugs and Biologics Market Share (2016-2018)
Table Genentech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Genentech Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Genentech Retinal Drugs and Biologics Market Share (2016-2018)
Table OCULAR THERAPEUTIX Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure OCULAR THERAPEUTIX Retinal Drugs and Biologics Market Share (2016-2018)
Table Bausch & Lomb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table UCBCares Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Global Famotidine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 16-Oct-2019        Price: US 3480 Onwards        Pages: 106
    Scope of the Report: The worldwide market for Famotidine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Famotidine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.......
  • Global Fosfomycin Sodium Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 16-Oct-2019        Price: US 3480 Onwards        Pages: 101
    Scope of the Report: The worldwide market for Fosfomycin Sodium is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Fosfomycin Sodium in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and a......
  • Global Hemp Market Growth 2019-2024
    Published: 16-Oct-2019        Price: US 3660 Onwards        Pages: 166
    According to this study, over the next five years the Hemp market will register a 24.0% CAGR in terms of revenue, the global market size will reach US$ 2826.6 million by 2024, from US$ 1195.8 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Hemp business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Hemp market by product type, application, key manu......
  • Global ELISpot and FluoroSpot Assay Market Growth (Status and Outlook) 2019-2024
    Published: 16-Oct-2019        Price: US 3660 Onwards        Pages: 118
    According to this study, over the next five years the ELISpot and FluoroSpot Assay market will register a 14.3% CAGR in terms of revenue, the global market size will reach US$ 321.2 million by 2024, from US$ 188.3 million in 2019. In particular, this report presents the global revenue market share of key companies in ELISpot and FluoroSpot Assay business, shared in Chapter 3. This report presents a comprehensive overview, market shares and growth opportunities of ELISpot and Fluor......
  • Global Artesunate Tablet Market Growth 2019-2024
    Published: 16-Oct-2019        Price: US 3660 Onwards        Pages: 134
    According to this study, over the next five years the Artesunate Tablet market will register a 7.6% CAGR in terms of revenue, the global market size will reach US$ 180.3 million by 2024, from US$ 134.4 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Artesunate Tablet business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Artesunate Tablet market by......
  • Global Mitogen Activated Protein Kinase 14 Market Professional Survey Report 2019
    Published: 15-Oct-2019        Price: US 3500 Onwards        Pages: 101
    The global Mitogen Activated Protein Kinase 14 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Mitogen Activated Protein Kinase 14 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Mitogen Activated Protein Kinase 14 market size by analyzing historical data and future prospect. Regionally, this repo......
  • Global Burkholderia Pseudomallei Infections Drug Market Professional Survey Report 2019
    Published: 15-Oct-2019        Price: US 3500 Onwards        Pages: 101
    The global Burkholderia Pseudomallei Infections Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Burkholderia Pseudomallei Infections Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Burkholderia Pseudomallei Infections Drug market size by analyzing historical data and future prospect. Reg......
  • Global Thrombocythaemia Myelofibrosis Treatment Market Professional Survey Report 2019
    Published: 15-Oct-2019        Price: US 3500 Onwards        Pages: 101
    The global Thrombocythaemia Myelofibrosis Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Thrombocythaemia Myelofibrosis Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Thrombocythaemia Myelofibrosis Treatment market size by analyzing historical data and future prospect. Region......
  • Global Myotonic Dystrophy Drug Market Professional Survey Report 2019
    Published: 15-Oct-2019        Price: US 3500 Onwards        Pages: 101
    The global Myotonic Dystrophy Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Myotonic Dystrophy Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Myotonic Dystrophy Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, appar......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs